Donald W. Northfelt - Division of Hematology and Medical Oncology, Mayo Clinic

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 437 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Figure S9 from PKMYT1 is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer

Anran Chen,Beom-Jun Kim, Aparna Mitra, Craig T. Vollert,Jonathan T. Lei,Diana Fandino,Meenakshi Anurag,Matthew V. Holt,Xuxu Gou, Jacob B. Pilcher,Matthew P. Goetz,Donald W. Northfelt,Susan G. Hilsenbeck,C. Gary Marshall,Marc L. Hyer,Robert Papp, Shou-Yun Yin,Carmine De Angelis,Rachel Schiff,Suzanne A.W. Fuqua,Cynthia X. Ma,Charles E. Foulds,Matthew J. Ellis

crossref（2024）

Cited0Views0Bibtex

Figure S6 from PKMYT1 is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer

crossref（2024）

Cited0Views0Bibtex

Figure S2 from PKMYT1 is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer

crossref（2024）

Cited0Views0Bibtex

Figure S7 from PKMYT1 is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer

crossref（2024）

Cited0Views0Bibtex

Figure S16 from PKMYT1 is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer

crossref（2024）

Cited0Views0Bibtex

Prospective Study of Supplemental Screening With Contrast-Enhanced Mammography in Women With Elevated Risk of Breast Cancer: Results of the Prevalence Round

Bhavika K Patel,Molly B Carnahan,Donald Northfelt, Karen Anderson,Gina L Mazza,Victor J Pizzitola,Marina E Giurescu,Roxanne Lorans,William G Eversman, Richard E Sharpe,Laura K Harper,Heidi Apsey,Patricia Cronin,Juliana Kling,Brenda Ernst, Jennifer Palmieri,Jessica Fraker, Lida Mina,Felipe Batalini,Barbara Pockaj

Journal of clinical oncology : official journal of the American Society of Clinical Oncologypp.JCO2202819-JCO2202819, (2024)

Cited0Views0WOSBibtex

Table S6 from PKMYT1 is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer

crossref（2024）

Cited0Views0Bibtex

Figure S8 from PKMYT1 is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer

crossref（2024）

Cited0Views0Bibtex

Table S1 from PKMYT1 is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer

crossref（2024）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn